• Matthieu Huet.
• Faculté des sciences pharmaceutiques et biologiques, 2, avenue du Professeur-Léon-Bernard, 35043 Rennes cedex, France. matthieuhuet29@gmail.com
• Bull Cancer. 2013 May 1; 100 (5): 485-95.

AbstractMany complementary and alternatives medicines are offered to patients with cancer. Among them, herbal medicines have a substantial place. These plants are mainly used to reduce adverse effects of anticancer treatments and for specific anticancer properties. Our review shows that only few clinical data support medicinal plants effectiveness in cancer patients. Arguments rely mainly on usual indications and pharmacological data for minimization of treatments toxicity while for the anticancer properties, on epidemiological and preclinical data. To inform and counsel patients and people around, healthcare professionals need to evaluate benefit-risk balance on evidence-based information. Because the medical decision should be shared with the patient, his beliefs and preferences have to be considered. When no adverse effect or drug interaction is associated with herbal medicine, we state that their use is acceptable. This paper discuss of potential risk and benefit of the most used medicinal plants by cancer patients.

23 keywords...

hide…